Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Latisha Doty and Alison Bocking have each lost more than 100 lbs. in the last two years—and gained a lifelong friend in the ...

Sugar substitutes, substance abuse, GLP-1 drugs, and the biggest clinical trials of the year—each had their place in our top ...

Internet-driven health obsessives were once dismissed as “cyberchondriacs”. But medical tech is increasingly mainstream. Apps ...

On the one hand, its impressive business performance can make investors ponder potential life-changing investment returns. Conversely, feeling confident in Hims & Hers Health can sometimes be ...

Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...

The weight-loss market began feeling some growing pains as the year ended, creating more wariness for the upcoming year. For 2025, competition and supply constraints are areas to watch.

A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...

A clinical stage biopharma firm in Miami is slashing its headcount after selling its female condom business to an investment ...

For example, a 2-ounce serving of rotisserie chicken packs just 80 calories and 16 grams of protein, making it a high-protein ...

Three unlikely winners of 2024 can lead the way in the year ahead. Some of the hottest stocks of 2024 may surprise you. A few ...

Worried about mental health effects of ozempic? Here's what recent studies reveal about safety concerns and what you should discuss with your doctor ...